The life sciences practice at ALTIUS is ‘always readily available and easily accessible’, representing companies in the pharmaceutical, medical devices, and biotech industries. The team that is ’very hands on, to the point, communicates fast, and delivers within deadlines’ is led by the experienced litigator Christophe Ronse, Philippe de Jong, and Kirian Claeyé, who is adept at life cycle management and advice on clinical trials.
Testimonials
Collated independently by Legal 500 research team.
‘Very fast, correct advice. Adapted to the real situation.’
‘The Altius team is always readily available and easily accessible. They accurately monitor projects and provide input based on sound, specific knowledge. ’
‘The individuals working at Altius have in-depth knowledge of the specific domains they advise in. They think along with the client also on strategic projects. ’
‘The team is very hands on, to the point, communicates fast, and delivers within deadlines. ’
‘Kirian Claeyé is an encyclopedia of medical law, always up to date and to the point. Unseen, unmatched! Very accessible and helpful. Despite these gifts, he remains modest.’
‘In life sciences, Altius has a great reputation. They understand the situation very quickly and can translate their proposal into 'human' terms. ’
‘Christophe and Kirian stand out because they really care for delivering a great service.'
Key clients
- Merck Sharp & Dohme (MSD)
- Novartis
- Bayer Pharma
- Ferring
- Gilead
- Equine America
- Azelis
- Beiersdorf
- Organon
- Midmark
- Hipra
- P3Lab
- AbbVie
Work highlights
- Advised Beiersdorf on the EU Medical Devices Regulation.
- Representing Bayer in the enforcement of orphan drug market exclusivity.
- Advised Merck Sharp & Dohme on the implementation of various new EU Directives and upcoming EU pharma reforms.
Practice head
The lawyer(s) leading their teams.
Christophe Ronse, Philippe de Jong, Kirian Claeyé